Acerta Pharma Bv

This early-stage study tested the safety and initial effectiveness of combining the drug acalabrutinib with other cancer medications for patients with chronic lymphocytic leukemia (CLL) and related blood cancers. It involved 69 patients, some who had been treated before and some …

This study tested a new combination of two drugs, acalabrutinib and ACP-319, for people with B-cell cancers like non-Hodgkin's lymphoma and multiple myeloma. The main goals were to find the safest dose and see if the treatment was effective at controlling the disease. It involved…

This early-stage study tested the safety and initial effectiveness of combining two drugs, acalabrutinib and pembrolizumab, for people with various blood cancers. It involved 161 participants with conditions like lymphoma and leukemia. The main goal was to see if the combination …

This study tested whether the drug acalabrutinib could help control chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in people whose cancer had returned after treatment or who had a specific high-risk genetic change called 17p deletion. The trial involved 48…